Guardian Pharmacy Services (GRDN) Cash & Equivalents (2023 - 2026)

Guardian Pharmacy Services has disclosed Cash & Equivalents across 4 years of filings, most recently posting $89.8 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 377.27% year-over-year to $89.8 million; the TTM figure through Jun 2026 stood at $89.8 million (up 377.27% YoY), while the FY2025 annual figure was $65.6 million, up 1308.13% from the prior year.
• Cash & Equivalents came in at $89.8 million for Q2 2026 at Guardian Pharmacy Services, up from $64.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $89.8 million in Q2 2026 to a low of $752000.0 in Q4 2023.
• Average Cash & Equivalents over 4 years is $36.9 million, with a median of $36.5 million recorded in 2025.
• The largest YoY upside for Cash & Equivalents was 1308.13% in 2025 against a maximum downside of 1.97% in 2025.
• Over 4 years, Cash & Equivalents stood at $752000.0 in 2023, then soared by 519.68% to $4.7 million in 2024, then jumped by 1308.13% to $65.6 million in 2025, then surged by 36.86% to $89.8 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $89.8 million in Q2 2026, $64.9 million in Q1 2026, and $65.6 million in Q4 2025.